Biden Regulatory Freeze Could Slam Brakes On SUNSET Reg Review Rule From HHS
Executive Summary
The tactic aims to allow the new Biden administration to scrutinize so-called “midnight rules” issued in the final days of the Trump administration before they take effect. One reg targeted by the freeze is the recent SUNSET rule from the US HHS, which would require the department and its agencies – including the FDA – to review all regulations every 10 years to determine whether they’re still necessary.
You may also be interested in...
Pew Urges Biden Administration To Rescind Trump Era Rules, Reform Diagnostics Regulatory Regime
The non-partisan policy think tank wants the administration to permanently rescind a number of recent Trump HHS policies, including one that stops the FDA from regulating laboratory developed tests.
Lawmakers Press CMS To Enact MCIT Breakthrough Device Coverage Rule
The Medicare rule, which was delayed by 60 days under a broader regulatory freeze, is seen as critical to the reimbursement of innovative devices.
Lawyer: Biden Reg Freeze Puts On Ice Potential Premarket Review Waivers For 84 Device Types
King & Spalding partner Kyle Sampson tells Medtech Insight that a joint US HHS/FDA notice that could exempt a plethora of medical devices from premarket review falls under a recent regulatory freeze from the Biden administration.